Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study.
about
Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal.Management of Pneumonia and Blood Stream Infections with New Antibiotic Adjuvant Entity (Ceftriaxone + Sulbactam + Disodium Edetate)- A Novel Way to Spare Carbapenems.Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains.
P2860
Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Incidence and impact on clinic ...... in ICU: a retrospective study.
@ast
Incidence and impact on clinic ...... in ICU: a retrospective study.
@en
Incidence and impact on clinic ...... in ICU: a retrospective study.
@nl
type
label
Incidence and impact on clinic ...... in ICU: a retrospective study.
@ast
Incidence and impact on clinic ...... in ICU: a retrospective study.
@en
Incidence and impact on clinic ...... in ICU: a retrospective study.
@nl
prefLabel
Incidence and impact on clinic ...... in ICU: a retrospective study.
@ast
Incidence and impact on clinic ...... in ICU: a retrospective study.
@en
Incidence and impact on clinic ...... in ICU: a retrospective study.
@nl
P2093
P2860
P356
P1476
Incidence and impact on clinic ...... in ICU: a retrospective study.
@en
P2093
Agnès Meybeck
Didier Dreyfuss
Guillaume Chevrel
Guilène Barnaud
Jean-Damien Ricard
Mathieu Eveillard
Roman Mounier
P2860
P2888
P356
10.1186/1471-2334-8-67
P577
2008-05-17T00:00:00Z
P5875
P6179
1006168749